• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥沙利铂诱导的结直肠癌患者外周神经毒性:机制、药代动力学及应对策略

Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies.

作者信息

Cheng Fang, Zhang Ruoqi, Sun Chen, Ran Qian, Zhang Cuihan, Shen Changhong, Yao Ziqing, Wang Miao, Song Lin, Peng Cheng

机构信息

State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Department of Pharmacy, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China.

出版信息

Front Pharmacol. 2023 Aug 1;14:1231401. doi: 10.3389/fphar.2023.1231401. eCollection 2023.

DOI:10.3389/fphar.2023.1231401
PMID:37593174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10427877/
Abstract

Oxaliplatin-based chemotherapy is a standard treatment approach for colorectal cancer (CRC). However, oxaliplatin-induced peripheral neurotoxicity (OIPN) is a severe dose-limiting clinical problem that might lead to treatment interruption. This neuropathy may be reversible after treatment discontinuation. Its complicated mechanisms are related to DNA damage, dysfunction of voltage-gated ion channels, neuroinflammation, transporters, oxidative stress, and mitochondrial dysfunction, Several strategies have been proposed to diminish OIPN without compromising the efficacy of adjuvant therapy, namely, combination with chemoprotectants (such as glutathione, Ca/Mg, ibudilast, duloxetine, ), chronomodulated infusion, dose reduction, reintroduction of oxaliplatin and topical administration [hepatic arterial infusion chemotherapy (HAIC), pressurized intraperitoneal aerosol chemotherapy (PIPAC), and hyperthermic intraperitoneal chemotherapy (HIPEC)]. This article provides recent updates related to the potential mechanisms, therapeutic strategies in treatment of OIPN, and pharmacokinetics of several methods of oxaliplatin administration in clinical trials.

摘要

基于奥沙利铂的化疗是结直肠癌(CRC)的标准治疗方法。然而,奥沙利铂诱导的周围神经毒性(OIPN)是一个严重的剂量限制性临床问题,可能导致治疗中断。这种神经病变在停药后可能是可逆的。其复杂的机制与DNA损伤、电压门控离子通道功能障碍、神经炎症、转运体、氧化应激和线粒体功能障碍有关。已经提出了几种在不影响辅助治疗疗效的情况下减少OIPN的策略,即与化学保护剂(如谷胱甘肽、钙/镁、异丁司特、度洛西汀)联合使用、时辰调制输注、剂量减少、重新引入奥沙利铂以及局部给药[肝动脉灌注化疗(HAIC)、加压腹腔内气溶胶化疗(PIPAC)和热腹腔内化疗(HIPEC)]。本文提供了与OIPN潜在机制、治疗策略以及临床试验中几种奥沙利铂给药方法的药代动力学相关的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1eb/10427877/c926b3f52db4/fphar-14-1231401-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1eb/10427877/234e493f8b29/fphar-14-1231401-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1eb/10427877/c926b3f52db4/fphar-14-1231401-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1eb/10427877/234e493f8b29/fphar-14-1231401-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1eb/10427877/c926b3f52db4/fphar-14-1231401-g002.jpg

相似文献

1
Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies.奥沙利铂诱导的结直肠癌患者外周神经毒性:机制、药代动力学及应对策略
Front Pharmacol. 2023 Aug 1;14:1231401. doi: 10.3389/fphar.2023.1231401. eCollection 2023.
2
Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment.奥沙利铂诱导的周围神经病:临床特征、发病机制、预防及治疗。
J Neurol. 2021 Sep;268(9):3269-3282. doi: 10.1007/s00415-020-09942-w. Epub 2020 May 30.
3
Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity.靶向 OCT2 用度洛西汀预防奥沙利铂诱导的周围神经毒性。
Cancer Res Commun. 2022 Nov;2(11):1334-1343. doi: 10.1158/2767-9764.crc-22-0172. Epub 2022 Nov 3.
4
Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design.通过腹腔镜途径采用加压雾化腹腔内化疗进行奥沙利铂剂量递增的I/II期研究(PIPOX试验)用于消化道癌(胃癌、小肠癌和结直肠癌)不可切除的腹膜转移:原理与设计
Pleura Peritoneum. 2018 Sep 15;3(3):20180120. doi: 10.1515/pp-2018-0120. eCollection 2018 Sep 1.
5
Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer.伊布地尔预防奥沙利铂所致急性神经毒性的前瞻性研究:评估转移性胃肠道癌患者初步疗效、耐受性和药代动力学相互作用的Ⅰ期临床研究。
Cancer Chemother Pharmacol. 2020 Oct;86(4):547-558. doi: 10.1007/s00280-020-04143-8. Epub 2020 Sep 19.
6
Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity.还原型谷胱甘肽在FOLFOX4辅助治疗结直肠癌中的应用:对奥沙利铂药代动力学、铂-DNA加合物形成及神经毒性的影响
Anticancer Drugs. 2009 Jun;20(5):396-402. doi: 10.1097/CAD.0b013e32832a2dc1.
7
Efficacy and safety of traditional plant-based medicines for preventing chronic oxaliplatin-induced peripheral neurotoxicity in patients with colorectal cancer: A systematic review and meta-analysis with core herb contribution.传统植物药预防结直肠癌患者奥沙利铂相关性慢性周围神经毒性的疗效和安全性:基于核心草药贡献的系统评价和荟萃分析。
J Ethnopharmacol. 2024 May 23;326:117735. doi: 10.1016/j.jep.2024.117735. Epub 2024 Jan 10.
8
Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.靶向溶酶体半胱氨酸蛋白酶组织蛋白酶 S 揭示了奥沙利铂诱导的周围神经病变的免疫调节治疗策略。
Theranostics. 2021 Mar 4;11(10):4672-4687. doi: 10.7150/thno.54793. eCollection 2021.
9
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.托吡酯可预防奥沙利铂相关的轴突过度兴奋和奥沙利铂诱导的周围神经毒性。
Neuropharmacology. 2020 Mar 1;164:107905. doi: 10.1016/j.neuropharm.2019.107905. Epub 2019 Dec 4.
10
Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer.III 期随机、安慰剂对照、双盲研究显示,单唾液酸四己糖神经节苷脂可预防 II/III 期结直肠癌奥沙利铂诱导的周围神经毒性。
Cancer Med. 2020 Jan;9(1):151-159. doi: 10.1002/cam4.2693. Epub 2019 Nov 13.

引用本文的文献

1
Mechanisms of cancer-induced neurophysiological dysfunction and therapeutic strategies.癌症诱导的神经生理功能障碍机制与治疗策略。
Discov Oncol. 2025 Sep 3;16(1):1678. doi: 10.1007/s12672-025-03520-0.
2
The Effect of Different Intraperitoneal Hyperthermic Chemotherapy (HIPEC) Regimens on Serum Electrolyte Levels: A Comparison of Oxaliplatin and Mitomycin C.不同腹腔热灌注化疗(HIPEC)方案对血清电解质水平的影响:奥沙利铂与丝裂霉素C的比较
Medicina (Kaunas). 2025 Jul 25;61(8):1345. doi: 10.3390/medicina61081345.
3
A placebo-controlled study of the doses and efficacy of mycelia for oxaliplatin-induced peripheral neuropathy in colorectal cancer.

本文引用的文献

1
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity.抑制 NHE1 转运活性和基因转录在奥沙利铂诱导的痛性周围神经毒性中的 DRG 神经元。
Sci Rep. 2023 Mar 9;13(1):3991. doi: 10.1038/s41598-023-31095-9.
2
A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice.一过性炎症反应导致小鼠奥沙利铂神经毒性。
Ann Clin Transl Neurol. 2022 Dec;9(12):1985-1998. doi: 10.1002/acn3.51691. Epub 2022 Nov 11.
3
NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy.
一项关于菌丝体对结直肠癌中奥沙利铂诱导的周围神经病变的剂量和疗效的安慰剂对照研究。
Front Oncol. 2025 Aug 11;15:1577848. doi: 10.3389/fonc.2025.1577848. eCollection 2025.
4
Microbiome as a predictive biomarker in locally advanced rectal cancer.微生物群作为局部晚期直肠癌的预测生物标志物
Microbiome Res Rep. 2025 Mar 24;4(2):18. doi: 10.20517/mrr.2024.85. eCollection 2025.
5
Colorectal Cancer: Therapeutic Approaches and Their Complications.结直肠癌:治疗方法及其并发症
Biomedicines. 2025 Jul 5;13(7):1646. doi: 10.3390/biomedicines13071646.
6
Independent risk and protective factors for oxaliplatin-induced hypersensitivity reactions: a retrospective study.奥沙利铂诱导的超敏反应的独立风险和保护因素:一项回顾性研究。
Front Pharmacol. 2025 Jul 8;16:1624322. doi: 10.3389/fphar.2025.1624322. eCollection 2025.
7
A real-world study of oxaliplatin-induced hypersensitivity in colorectal cancer treatment based on the pharmacovigilance system in China: a cohort study.基于中国药物警戒系统的结直肠癌治疗中奥沙利铂诱导超敏反应的真实世界研究:一项队列研究
J Gastrointest Oncol. 2025 Jun 30;16(3):978-985. doi: 10.21037/jgo-2025-312. Epub 2025 Jun 20.
8
Colorectal Cancer with Ovarian Metastasis After Panitumumab and FOLFOX4: A Case Report.帕尼单抗和FOLFOX4治疗后出现卵巢转移的结直肠癌:一例报告
Am J Case Rep. 2025 Jun 25;26:e947300. doi: 10.12659/AJCR.947300.
9
Advances in hepatic arterial perfusion chemotherapy for hepatic metastases.肝转移瘤肝动脉灌注化疗的进展
Front Oncol. 2025 Jun 5;15:1544061. doi: 10.3389/fonc.2025.1544061. eCollection 2025.
10
Antioxidants in cancer therapy mitigating lipid peroxidation without compromising treatment through nanotechnology.癌症治疗中的抗氧化剂通过纳米技术减轻脂质过氧化而不影响治疗效果。
Discov Nano. 2025 Apr 24;20(1):70. doi: 10.1186/s11671-025-04248-0.
NET 触发 NLRP3 激活和白细胞介素 18 释放驱动奥沙利铂诱导的周围神经病变。
Cancer Immunol Res. 2022 Dec 2;10(12):1542-1558. doi: 10.1158/2326-6066.CIR-22-0197.
4
Interpretation of the OPRA Study: Are Our Criteria Reliable Enough to Recommend Watch and Wait?OPRA研究解读:我们的标准是否足够可靠以推荐观察等待?
J Clin Oncol. 2023 Jan 10;41(2):416-417. doi: 10.1200/JCO.22.01260. Epub 2022 Sep 20.
5
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?钠钙交换蛋白 2:在奥沙利铂诱导的周围神经毒性和轴突损伤中起关键作用?
Int J Mol Sci. 2022 Sep 2;23(17):10063. doi: 10.3390/ijms231710063.
6
Sex-related differences in oxaliplatin-induced changes in the expression of transient receptor potential channels and their contribution to cold hypersensitivity.奥沙利铂诱导的瞬时受体电位通道表达变化的性别差异及其对冷敏感的贡献。
Neurosci Lett. 2022 Sep 25;788:136863. doi: 10.1016/j.neulet.2022.136863. Epub 2022 Sep 5.
7
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Induction or Consolidation Chemotherapy?局部晚期直肠癌的全新辅助治疗:诱导化疗还是巩固化疗?
J Clin Oncol. 2022 Aug 10;40(23):2515-2519. doi: 10.1200/JCO.22.00506. Epub 2022 Jun 20.
8
Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial.III 期 ACHIEVE 试验:奥沙利铂和氟嘧啶类辅助治疗 III 期结肠癌患者 3 个月与 6 个月的最终分析。
J Clin Oncol. 2022 Oct 10;40(29):3419-3429. doi: 10.1200/JCO.21.02628. Epub 2022 May 5.
9
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.直肠癌患者接受全新辅助治疗后的器官保存。
J Clin Oncol. 2022 Aug 10;40(23):2546-2556. doi: 10.1200/JCO.22.00032. Epub 2022 Apr 28.
10
An Evidence-Based Guideline for Surveillance of Patients after Curative Treatment for Colon and Rectal Cancer.结直肠癌根治性治疗后患者监测的循证指南。
Curr Oncol. 2022 Jan 30;29(2):724-740. doi: 10.3390/curroncol29020062.